Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy

<p dir="ltr">Exosomes are recognized as new therapeutic targets for cancer biomedicine and cancer immunotherapy [1]. More recently, emerging roles of exosomes as promising diagnostic tools and predictive biomarkers for cancer immunotherapy have been reported. Structurally, exosomes a...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Reem Saleh (3513056) (author)
مؤلفون آخرون: Eyad Elkord (5396390) (author)
منشور في: 2020
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513512275968000
author Reem Saleh (3513056)
author2 Eyad Elkord (5396390)
author2_role author
author_facet Reem Saleh (3513056)
Eyad Elkord (5396390)
author_role author
dc.creator.none.fl_str_mv Reem Saleh (3513056)
Eyad Elkord (5396390)
dc.date.none.fl_str_mv 2020-07-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.3390/vaccines8030390
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Exosomes_Biological_Carriers_and_Promising_Tools_for_Cancer_Immunotherapy/26114464
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
cancer
exosomes
tumor microenvironment
immunosuppression
cancer immunotherapy
dc.title.none.fl_str_mv Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Exosomes are recognized as new therapeutic targets for cancer biomedicine and cancer immunotherapy [1]. More recently, emerging roles of exosomes as promising diagnostic tools and predictive biomarkers for cancer immunotherapy have been reported. Structurally, exosomes are small extracellular vesicles with 30 to 150 nm diameter, originate from one cell type (donor cell) and act as biological carriers [1]. They mediate cell-to-cell communication and exert biological activities by delivering their cargo contents, such as DNA, RNA, proteins or specific drugs, into target or recipient cells [2,3]. Exosomes are secreted from various cell types, including tumor and immune cells, and are capable of modifying the pathophysiological condition of recipient cells to convey messages which regulate distinct biological functions and transduce intercellular signaling [4].</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccines<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/vaccines8030390" target="_blank">https://dx.doi.org/10.3390/vaccines8030390</a></p>
eu_rights_str_mv openAccess
id Manara2_dc7c531734497ecd79a7eda5b44eedcd
identifier_str_mv 10.3390/vaccines8030390
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/26114464
publishDate 2020
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Exosomes: Biological Carriers and Promising Tools for Cancer ImmunotherapyReem Saleh (3513056)Eyad Elkord (5396390)Biomedical and clinical sciencesImmunologyOncology and carcinogenesisPharmacology and pharmaceutical sciencescancerexosomestumor microenvironmentimmunosuppressioncancer immunotherapy<p dir="ltr">Exosomes are recognized as new therapeutic targets for cancer biomedicine and cancer immunotherapy [1]. More recently, emerging roles of exosomes as promising diagnostic tools and predictive biomarkers for cancer immunotherapy have been reported. Structurally, exosomes are small extracellular vesicles with 30 to 150 nm diameter, originate from one cell type (donor cell) and act as biological carriers [1]. They mediate cell-to-cell communication and exert biological activities by delivering their cargo contents, such as DNA, RNA, proteins or specific drugs, into target or recipient cells [2,3]. Exosomes are secreted from various cell types, including tumor and immune cells, and are capable of modifying the pathophysiological condition of recipient cells to convey messages which regulate distinct biological functions and transduce intercellular signaling [4].</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccines<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/vaccines8030390" target="_blank">https://dx.doi.org/10.3390/vaccines8030390</a></p>2020-07-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/vaccines8030390https://figshare.com/articles/journal_contribution/Exosomes_Biological_Carriers_and_Promising_Tools_for_Cancer_Immunotherapy/26114464CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/261144642020-07-01T00:00:00Z
spellingShingle Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
Reem Saleh (3513056)
Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
cancer
exosomes
tumor microenvironment
immunosuppression
cancer immunotherapy
status_str publishedVersion
title Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
title_full Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
title_fullStr Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
title_full_unstemmed Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
title_short Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
title_sort Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy
topic Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
cancer
exosomes
tumor microenvironment
immunosuppression
cancer immunotherapy